title: Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT).
abstract: The aim of this study was to investigate the effect of resveratrol on the idiopathic bleomycin (BLM)-induced pulmonary fibrosis, which is increasingly recognized as an epithelial-to-mesenchymal transition (EMT)-associated disease.
  
  
  
  We evaluated the effect of resveratrol on the BLM-induced fibrosis in a mouse model, via monitoring the pathological chance in mice lung, the mice body weight change and the mice death. And we also explored the regulation by BLM on (and) resveratrol on the expression and activity of Sirt 1 and on the expression of epithelial-to-mesenchymal transition (EMT)-associated markers in mice lung.
  
  
  
  It was demonstrated that resveratrol ameliorated the BLM-induced fibrosis-like pathological change in mice lung, inhibited BLM-induced mice body weight loss and death. Moreover, resveratrol also inhibited the BLM-induced EMT-associated molecular events, such as reduced E-cadherin and elevated Collagen I and α-SMA. We also confirmed the amelioration by resveratrol on the BLM-mediated inhibition of Sirt 1 in expression and activity in mice lung.
  
  
  
  Our study confirmed the inhibitory role of resveratrol in the BLM-induced pulmonary fibrosis in a mouse model. Resveratrol ameliorated the BLM-induced pathological change of fibrosis, mice body weight loss and death. And such amelioration might be associated with the activation of Sirt 1 in mice lung. The present study implied that resveratrol might be a promising agent for effective control the pulmonary fibrosis.
authors.affiliation: Medical Inspection Center, Anhui University of Science and Technology, Huainan, China. wujing8016@163.com.
authors.forename: L
authors.initials: L
authors.lastname: Rong
authors.forename: J
authors.initials: J
authors.lastname: Wu
authors.forename: W
authors.initials: W
authors.lastname: Wang
authors.forename: R-P
authors.initials: RP
authors.lastname: Zhao
authors.forename: X-W
authors.initials: XW
authors.lastname: Xu
authors.forename: D
authors.initials: D
authors.lastname: Hu
mesh_terms: D000818:Animals; D001761:Bleomycin / Q000633:toxicity; D015820:Cadherins / Q000378:metabolism; D004789:Enzyme Activation; D058750:Epithelial-Mesenchymal Transition / Q000187:drug effects*; D051379:Mice; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D000077185:Resveratrol; D056564:Sirtuin 1 / Q000378:metabolism*; D013267:Stilbenes / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D015820:Cadherins; D013267:Stilbenes; D001761:Bleomycin; C470545:Sirt1 protein, mouse; D056564:Sirtuin 1; D000077185:Resveratrol